Single-crystal X-ray study T = 180 K Mean '(C±C) = 0.006 A Ê Disorder in main residue R factor = 0.052 wR factor = 0.128 Data-to-parameter ratio = 6.0
The H3Á Á ÁO6 and H4BÁ Á ÁO6 hydrogen bonds form ribbons of molecules parallel to the b axis. These ribbons stack parallel to the a axis to form sheets. The stacks are held together via %-stacking interactions [cytidine±cytidine i = 3.419 A Ê and cytidine±cytidine ii = 3.333 A Ê ; symmetry codes: (i) 1 À x, Ày, 1 2 + z; (ii) 2 À x, Ày, H ÐH3 H hydroxyl group hydrogen bonds to the methanol O atom (for each of the disorder sites). There is a correlation between the location of the >C2
H ÐCH 2 OH substituent and the methanol disorder sites. For site 1, the methanol molecule is located at the C31Ð O31 and C31
H ÐO31 H sites, for site 2 at the C21 H ÐO21 H site, and for site 3 at the C21ÐO21 site. See Table 2 for the hydrogenbonding geometries (including the disordered structure).
The conclusion from the X-ray data is supported by the high-®eld 13 C NMR spectrum.
Experimental
Compound (I): to a solution of 5-iodoisocytidine (0.36 g, 1 mmol) in DMSO/ t BuOH (1:1, 40 ml) was added t BuOK (0.45 g, 4 mmol). The reaction mixture was heated at 333 K for 24 h. The solution was neutralized with 0.5 M aqueous HCl, evaporated to dryness and puri®ed over silica gel to give the anhydro derivative. The anhydro derivative was dissolved in 0.2 M Ba(OH) 2 (10 ml) and heated at 373 K for 1 h. The solution was neutralized with 0.5 M HCl and evaporated to dryness. The residue was puri®ed over HPLC on C-18 reverse-phase column (H 2 O/MeOH) to give (I) (0.04 g, 16%) as a white powder. Compound (I) was crystallized from MeOH (m.p. 454 K). 
Crystal data

Data collection
Nonius KappaCCD diffractometer CCD 9 scans Absorption correction: none 13 640 measured re¯ections 1237 independent re¯ections 1078 re¯ections with I > 2'(I) Figure 1 View of the title compound. Displacement ellipsoids are shown at the 35% probability level. Only one orientation of the disordered CH 2 OH group is shown.
Table 2
Hydrogen-bonding geometry (A Ê , ). H 1 were allowed to re®ne with a U iso value of 1.1U eq (C2 H ). The methanol molecule of solvation is also disordered and each orientation was re®ned as a rigid group (CÐH = 0.99 A Ê , CÐO = 1.45 A Ê and OÐH = 0.84 A Ê , tetrahedral angles). One orientation (C21/H21AÐC/O21/ H21) was re®ned with occupancy 0.3333, as was the second (C21 H / H21DÐF/O21 H /H21 H ). For these two orientations, the C and O atoms were re®ned with individual isotropic displacement parameters. The third orientation exhibited high thermal motion and was split into two groups (C31/H31AÐC/O31/H31 and C31 H /H31DÐF/O31 H /H31 H ) with occupancy 0.1666 and one isotropic displacement parameter for both C and both O atoms. All H atoms (except H2 H 1) were included with the riding model (or were part of a rigid group) with program defaults. The largest shift (0.034) occurred for the rotz parameter of the O31 rigid group. The average shift was 0.003. 433 Friedel pairs were merged for the ®nal cycles of re®nement. The absolute structure was assumed from the synthesis.
Data collection: COLLECT (Nonius, 1997±2000); cell re®nement: HKL SCALEPACK (Otwinowski & Minor, 1997) ; data reduction: HKL DENZO (Otwinowski & Minor, 1997) and SCALEPACK; program(s) used to solve structure: SHELXTL (Sheldrick, 1997); program(s) used to re®ne structure: SHELXTL; molecular graphics: SHELXTL; software used to prepare material for publication: SHELXTL. Isomeric nucleosides (or isonucleosides), a novel class of nucleosides, have attracted much interest recently because of their significant anti-HIV and anti-HSV activity, as well as their stability towards acidic and enzymatic deamination (Nair & Jahnke, 1995) . For example, 4(S)-(6-amino-9H-purin-9-yl)-tetrahydro-1(S)-furanmethanol (IsoddA), an isomeric dideoxynucleoside synthesized in our laboratory, has antiviral activity against HIV-1 and HIV-2 (Nair et al., 1995; Nair & Nuesca, 1992) . In addition, it has been reported that the isodeoxynucleoside, IsodG, with guanine as the nucleobase, has activity against HSV-1 and HSV-2 (Kakefuda et al., 1994) . Our interest in isomeric nucleosides with new nucleobases led us to the synthesis 6-oxoisocytidine (I). However, in the literature, there is some ambiguity about the structure of the base moiety of 6-oxocytidine. Two different structures have been suggested for this base moiety in compounds (II) (Falco et al., 1970) and (III) (Lipkin et al., 1968) . Thus, it was important, not only to synthesize compound (I) for antiviral studies, but, prior to those biological studies, it was important to establish unequivocally the structure of the target molecule by physicochemical techniques including single-crystal X-ray data. The target nucleoside (I) was synthesized from 5-iodoisocytidine via anhydronucleoside intermediate.
The furanose ring adopts a C2′-envelope conformation. The envelope (O1′/C3′/C4′/C5′) is nearly perpendicular [dihedral angle = 89.5 (2)°] to the planar cytidine ring (N1/C2/N3/C4/C5/C6; r.m.s. deviation = 0.003 Å). The CH 2 OH equitorial substituent at C2′ exhibits threefold disorder, with each of the C2′-C6′ anti conformers equally represented.
[The C6′-O6′ orientation is anti to C2′-C3′ (site 1), C6′B-O6′B is anti to C2′-O1′ (site 2), and C6′C-O6′C is anti to
C2′-H2′1 (site 3).]
The H3···O6 and H4B···O6 hydrogen bonds form ribbons of molecules parallel to the b axis. These ribbons stack There is a correlation between the location of the >C2′-CH 2 OH substituent and the methanol disorder sites. For site 1, the methanol molecule is located at the C31-O31 and C31′-O31 sites, for site 2 at the C21′-O21′ site, and for site 3 at the C21-O21 site. See Table 3 for the hydrogen-bonding geometries (including the disordered structure).
The conclusion from the X-ray data is supported by the high-field 13 C NMR spectrum.
S2. Experimental
Compound A: to a solution of 5-iodoisocytidine (0.36 g, 1 mmol) in DMSO/t-BuOH (1:1, 40 ml) was added t-BuOK HCl, evaporated to dryness and purified over silica gel to give the anhydro derivative. 
S3. Refinement
The CH 2 OH substituent at C2′ is disordered by rotation about the C2′-C6′ bond to three orientations of equal occupancy
(1/3). In one orientation (C6′/H6′1/H6′2/O6′/H6′), the C-O bond is anti to the C2′-C3′ bond, another (C6′B/H6′3/H6′4/O6′B/H6′B) has the C-O bond anti to the C2′-O1′ bond, and the third (C6′C/H6′5/H6′6/O6′C/H6′C) has the C-O bond anti to the C2′-H2′1 bond. The occupancies of each refined to approximately 1/3 so each was fixed to 0.3333 for the final refinement cycles. The coordinates of H2′1 were allowed to refine with a U iso vale of 1.1U iso (C2′).
The methanol molecule of solvation is also disordered and each orientation was refined as a rigid group (C-H = 0.99 Å, View of the title compound. Displacement ellipsoids are shown at the 35% probability level. Only one orientation of the disorder CH 2 OH group is shown.
4-(R)-[4-amino-2,6-dioxopyrimidine-1-yl]-3(S)-hydroxy-2(R)-furan methanol solvate
Crystal data ) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F 2 are statistically about twice as large as those based on F, and R-factors based on ALL data will be even larger. 
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å
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